Nancy Krebs
Concepts (740)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Zinc | 113 | 2026 | 295 | 15.580 |
Why?
| | Infant Nutritional Physiological Phenomena | 42 | 2026 | 149 | 9.050 |
Why?
| | Dietary Supplements | 61 | 2026 | 576 | 8.020 |
Why?
| | Nutritional Status | 46 | 2026 | 354 | 6.530 |
Why?
| | Maternal Nutritional Physiological Phenomena | 19 | 2026 | 181 | 5.650 |
Why?
| | Micronutrients | 28 | 2026 | 96 | 5.640 |
Why?
| | Developing Countries | 78 | 2026 | 318 | 5.490 |
Why?
| | Milk, Human | 34 | 2026 | 172 | 5.310 |
Why?
| | Diet | 64 | 2026 | 1273 | 5.220 |
Why?
| | Breast Feeding | 48 | 2026 | 448 | 5.090 |
Why?
| | Infant Food | 25 | 2025 | 64 | 4.010 |
Why?
| | Intestinal Absorption | 38 | 2026 | 103 | 3.840 |
Why?
| | Meat | 13 | 2021 | 93 | 3.770 |
Why?
| | Infant | 158 | 2026 | 10034 | 3.380 |
Why?
| | Premature Birth | 25 | 2026 | 380 | 3.350 |
Why?
| | Child Development | 21 | 2024 | 484 | 3.290 |
Why?
| | Iron | 22 | 2026 | 359 | 3.120 |
Why?
| | Pregnancy Outcome | 32 | 2025 | 476 | 3.040 |
Why?
| | Nutritional Requirements | 25 | 2019 | 76 | 3.040 |
Why?
| | Preconception Care | 12 | 2026 | 50 | 2.990 |
Why?
| | Infant, Newborn | 125 | 2026 | 6429 | 2.980 |
Why?
| | Food, Fortified | 22 | 2026 | 44 | 2.910 |
Why?
| | Pregnancy | 140 | 2026 | 7190 | 2.860 |
Why?
| | Infant Mortality | 36 | 2023 | 123 | 2.770 |
Why?
| | Phytic Acid | 19 | 2017 | 35 | 2.670 |
Why?
| | Anemia, Iron-Deficiency | 11 | 2025 | 62 | 2.480 |
Why?
| | Growth Disorders | 12 | 2022 | 86 | 2.450 |
Why?
| | Infant Formula | 12 | 2026 | 71 | 2.340 |
Why?
| | Iron, Dietary | 9 | 2019 | 23 | 2.340 |
Why?
| | Guatemala | 39 | 2026 | 345 | 2.270 |
Why?
| | Prenatal Care | 24 | 2026 | 307 | 2.250 |
Why?
| | Perinatal Death | 13 | 2023 | 26 | 2.210 |
Why?
| | Child Health | 20 | 2023 | 157 | 2.170 |
Why?
| | Stillbirth | 25 | 2023 | 77 | 2.140 |
Why?
| | Female | 275 | 2026 | 78271 | 2.080 |
Why?
| | Fetal Development | 8 | 2026 | 299 | 2.010 |
Why?
| | Humans | 353 | 2026 | 144759 | 1.960 |
Why?
| | Poverty | 13 | 2023 | 529 | 1.930 |
Why?
| | Lactation | 16 | 2025 | 192 | 1.910 |
Why?
| | Obesity, Morbid | 7 | 2021 | 281 | 1.840 |
Why?
| | Pregnancy Complications, Infectious | 12 | 2026 | 428 | 1.830 |
Why?
| | Dietary Proteins | 12 | 2026 | 136 | 1.820 |
Why?
| | Azithromycin | 10 | 2026 | 104 | 1.780 |
Why?
| | Dairy Products | 3 | 2021 | 31 | 1.770 |
Why?
| | Homeostasis | 21 | 2015 | 640 | 1.730 |
Why?
| | Infant Health | 10 | 2023 | 25 | 1.720 |
Why?
| | Obesity | 24 | 2024 | 3077 | 1.720 |
Why?
| | Cesarean Section | 8 | 2021 | 224 | 1.710 |
Why?
| | Pakistan | 32 | 2026 | 78 | 1.700 |
Why?
| | Energy Intake | 13 | 2026 | 499 | 1.660 |
Why?
| | Feces | 27 | 2025 | 513 | 1.660 |
Why?
| | Body Mass Index | 23 | 2023 | 2438 | 1.620 |
Why?
| | Delivery, Obstetric | 20 | 2026 | 160 | 1.600 |
Why?
| | Gastric Bypass | 6 | 2019 | 125 | 1.590 |
Why?
| | Trace Elements | 13 | 2022 | 52 | 1.560 |
Why?
| | Infant, Small for Gestational Age | 8 | 2026 | 109 | 1.540 |
Why?
| | Pregnancy Complications | 17 | 2025 | 592 | 1.480 |
Why?
| | Mothers | 13 | 2024 | 775 | 1.470 |
Why?
| | Birth Weight | 23 | 2025 | 522 | 1.440 |
Why?
| | Maternal Mortality | 18 | 2025 | 53 | 1.410 |
Why?
| | Gastrointestinal Microbiome | 10 | 2025 | 771 | 1.360 |
Why?
| | Anemia | 10 | 2026 | 188 | 1.350 |
Why?
| | Malnutrition | 6 | 2026 | 86 | 1.320 |
Why?
| | Growth | 7 | 2020 | 49 | 1.250 |
Why?
| | Adult | 121 | 2026 | 40449 | 1.230 |
Why?
| | Maternal Health | 6 | 2023 | 52 | 1.210 |
Why?
| | Zea mays | 12 | 2017 | 43 | 1.180 |
Why?
| | Anthropometry | 13 | 2024 | 200 | 1.170 |
Why?
| | Nutrition Assessment | 5 | 2025 | 92 | 1.170 |
Why?
| | Infant, Premature | 9 | 2023 | 611 | 1.150 |
Why?
| | Infant, Low Birth Weight | 15 | 2026 | 153 | 1.130 |
Why?
| | Gestational Age | 16 | 2026 | 975 | 1.130 |
Why?
| | Child, Preschool | 54 | 2026 | 11787 | 1.110 |
Why?
| | Child | 71 | 2024 | 22633 | 1.110 |
Why?
| | Zinc Isotopes | 22 | 2011 | 22 | 1.100 |
Why?
| | Child Nutritional Physiological Phenomena | 9 | 2019 | 106 | 1.100 |
Why?
| | India | 21 | 2026 | 218 | 1.060 |
Why?
| | Gastrectomy | 3 | 2021 | 161 | 1.050 |
Why?
| | Pre-Eclampsia | 5 | 2023 | 204 | 1.020 |
Why?
| | Feeding Behavior | 12 | 2023 | 684 | 1.020 |
Why?
| | Prospective Studies | 51 | 2026 | 7990 | 1.010 |
Why?
| | Rural Population | 18 | 2022 | 650 | 1.000 |
Why?
| | Biological Availability | 22 | 2022 | 142 | 0.990 |
Why?
| | Nutritional Sciences | 5 | 2019 | 38 | 0.970 |
Why?
| | Body Composition | 10 | 2025 | 706 | 0.960 |
Why?
| | Biomarkers | 22 | 2025 | 4271 | 0.950 |
Why?
| | Food | 3 | 2020 | 149 | 0.940 |
Why?
| | Anti-Bacterial Agents | 9 | 2026 | 1907 | 0.940 |
Why?
| | Zambia | 18 | 2024 | 57 | 0.940 |
Why?
| | Young Adult | 59 | 2026 | 14105 | 0.930 |
Why?
| | Double-Blind Method | 23 | 2026 | 2029 | 0.920 |
Why?
| | Vitamins | 4 | 2025 | 178 | 0.910 |
Why?
| | Male | 121 | 2026 | 72315 | 0.900 |
Why?
| | Registries | 27 | 2023 | 2385 | 0.900 |
Why?
| | Democratic Republic of the Congo | 15 | 2026 | 33 | 0.890 |
Why?
| | Weaning | 6 | 2024 | 46 | 0.870 |
Why?
| | Postpartum Period | 7 | 2026 | 365 | 0.850 |
Why?
| | Birth Intervals | 2 | 2021 | 23 | 0.850 |
Why?
| | Vaginal Birth after Cesarean | 2 | 2021 | 27 | 0.840 |
Why?
| | Perinatal Mortality | 10 | 2022 | 21 | 0.840 |
Why?
| | Powders | 10 | 2025 | 44 | 0.820 |
Why?
| | Weight Gain | 9 | 2026 | 556 | 0.810 |
Why?
| | Congenital Abnormalities | 3 | 2020 | 104 | 0.780 |
Why?
| | Premenopause | 3 | 2021 | 123 | 0.780 |
Why?
| | Anastomosis, Roux-en-Y | 2 | 2021 | 26 | 0.770 |
Why?
| | Maternal Health Services | 6 | 2019 | 102 | 0.760 |
Why?
| | Education, Medical | 4 | 2019 | 274 | 0.750 |
Why?
| | Women's Health | 13 | 2023 | 310 | 0.750 |
Why?
| | Hemoglobins | 8 | 2025 | 384 | 0.750 |
Why?
| | Sodium Chloride, Dietary | 4 | 2026 | 31 | 0.730 |
Why?
| | Antibiotic Prophylaxis | 5 | 2026 | 129 | 0.730 |
Why?
| | Amino Acids, Branched-Chain | 2 | 2021 | 39 | 0.730 |
Why?
| | Obstetric Labor Complications | 6 | 2020 | 38 | 0.720 |
Why?
| | Vegetables | 2 | 2022 | 170 | 0.720 |
Why?
| | Overweight | 7 | 2023 | 609 | 0.700 |
Why?
| | Edible Grain | 7 | 2014 | 49 | 0.700 |
Why?
| | Inflammation | 6 | 2022 | 2878 | 0.700 |
Why?
| | Cesarean Section, Repeat | 1 | 2021 | 11 | 0.700 |
Why?
| | Sepsis | 5 | 2026 | 640 | 0.680 |
Why?
| | Weight Reduction Programs | 2 | 2013 | 136 | 0.680 |
Why?
| | Nutritive Value | 3 | 2024 | 38 | 0.670 |
Why?
| | Body Height | 6 | 2022 | 202 | 0.670 |
Why?
| | Deficiency Diseases | 6 | 2019 | 10 | 0.640 |
Why?
| | Models, Biological | 9 | 2016 | 1821 | 0.630 |
Why?
| | Bangladesh | 9 | 2026 | 62 | 0.630 |
Why?
| | Recommended Dietary Allowances | 3 | 2018 | 16 | 0.620 |
Why?
| | Dietary Approaches To Stop Hypertension | 1 | 2020 | 13 | 0.620 |
Why?
| | Milk Banks | 1 | 2019 | 1 | 0.620 |
Why?
| | Ultrasonography, Prenatal | 6 | 2020 | 294 | 0.610 |
Why?
| | Adolescent | 48 | 2025 | 22428 | 0.610 |
Why?
| | Malabsorption Syndromes | 1 | 2019 | 16 | 0.600 |
Why?
| | Health Education | 4 | 2018 | 358 | 0.600 |
Why?
| | Pregnancy Complications, Parasitic | 1 | 2019 | 9 | 0.590 |
Why?
| | Kenya | 12 | 2026 | 129 | 0.590 |
Why?
| | Dietary Fats | 2 | 2020 | 314 | 0.590 |
Why?
| | Iron Metabolism Disorders | 2 | 2015 | 6 | 0.590 |
Why?
| | Longitudinal Studies | 20 | 2026 | 2947 | 0.580 |
Why?
| | Maternal Death | 4 | 2020 | 15 | 0.580 |
Why?
| | Developed Countries | 2 | 2015 | 38 | 0.570 |
Why?
| | Aspirin | 7 | 2026 | 399 | 0.570 |
Why?
| | Organic Chemicals | 1 | 2020 | 127 | 0.570 |
Why?
| | Quality Assurance, Health Care | 1 | 2020 | 340 | 0.560 |
Why?
| | Avitaminosis | 1 | 2018 | 6 | 0.560 |
Why?
| | Nutrition Therapy | 2 | 2019 | 37 | 0.550 |
Why?
| | Parity | 8 | 2023 | 109 | 0.550 |
Why?
| | Malaria | 1 | 2019 | 73 | 0.550 |
Why?
| | Metabolomics | 2 | 2021 | 727 | 0.540 |
Why?
| | Enteritis | 1 | 2019 | 103 | 0.540 |
Why?
| | RNA, Ribosomal, 16S | 2 | 2017 | 558 | 0.540 |
Why?
| | Body Size | 6 | 2019 | 95 | 0.530 |
Why?
| | Prevalence | 14 | 2025 | 2834 | 0.520 |
Why?
| | Diarrhea | 5 | 2022 | 192 | 0.510 |
Why?
| | Body Weight | 13 | 2019 | 976 | 0.510 |
Why?
| | Weight Loss | 2 | 2013 | 836 | 0.500 |
Why?
| | Insulin | 7 | 2021 | 2507 | 0.490 |
Why?
| | Metabolome | 1 | 2020 | 384 | 0.480 |
Why?
| | Leptin | 5 | 2018 | 245 | 0.470 |
Why?
| | Vitamin E | 1 | 2016 | 121 | 0.470 |
Why?
| | Global Health | 10 | 2025 | 401 | 0.470 |
Why?
| | Child Nutrition Sciences | 1 | 2015 | 7 | 0.460 |
Why?
| | Cross-Sectional Studies | 26 | 2026 | 5868 | 0.450 |
Why?
| | Gastrointestinal Absorption | 1 | 2014 | 5 | 0.440 |
Why?
| | Starch | 1 | 2015 | 22 | 0.440 |
Why?
| | Nutrition Policy | 6 | 2017 | 58 | 0.440 |
Why?
| | Pregnancy Trimester, First | 7 | 2023 | 136 | 0.440 |
Why?
| | Prenatal Nutritional Physiological Phenomena | 5 | 2024 | 59 | 0.430 |
Why?
| | Calcium | 5 | 2022 | 1183 | 0.430 |
Why?
| | Brain | 2 | 2017 | 2933 | 0.420 |
Why?
| | Oryza | 2 | 2026 | 32 | 0.420 |
Why?
| | Infant, Premature, Diseases | 1 | 2015 | 111 | 0.420 |
Why?
| | Cohort Studies | 14 | 2021 | 5960 | 0.420 |
Why?
| | Age Factors | 9 | 2015 | 3333 | 0.410 |
Why?
| | Adiposity | 3 | 2018 | 543 | 0.410 |
Why?
| | Health Promotion | 4 | 2023 | 774 | 0.410 |
Why?
| | Risk Factors | 26 | 2025 | 10779 | 0.410 |
Why?
| | Aging | 6 | 2018 | 1966 | 0.410 |
Why?
| | Educational Status | 11 | 2022 | 467 | 0.400 |
Why?
| | Calcium, Dietary | 5 | 2022 | 53 | 0.400 |
Why?
| | Diet, Mediterranean | 2 | 2024 | 28 | 0.400 |
Why?
| | Randomized Controlled Trials as Topic | 10 | 2026 | 1720 | 0.400 |
Why?
| | Socioeconomic Factors | 13 | 2024 | 1326 | 0.400 |
Why?
| | Pediatrics | 6 | 2018 | 1114 | 0.400 |
Why?
| | Income | 9 | 2023 | 202 | 0.390 |
Why?
| | Regression Analysis | 10 | 2016 | 1003 | 0.390 |
Why?
| | Dysprosium | 2 | 2010 | 2 | 0.380 |
Why?
| | Labor, Obstetric | 3 | 2026 | 66 | 0.380 |
Why?
| | Antioxidants | 1 | 2016 | 549 | 0.380 |
Why?
| | Hypertension, Pregnancy-Induced | 2 | 2023 | 67 | 0.370 |
Why?
| | Flour | 4 | 2015 | 7 | 0.370 |
Why?
| | Occupational Health Services | 1 | 2012 | 37 | 0.370 |
Why?
| | Pregnancy Trimester, Third | 3 | 2017 | 115 | 0.370 |
Why?
| | Triticum | 2 | 2009 | 17 | 0.360 |
Why?
| | Metagenome | 1 | 2013 | 149 | 0.360 |
Why?
| | Heme | 1 | 2012 | 89 | 0.360 |
Why?
| | Glucocorticoids | 4 | 2016 | 535 | 0.350 |
Why?
| | Dietary Carbohydrates | 2 | 2010 | 151 | 0.350 |
Why?
| | Neurodevelopmental Disorders | 3 | 2023 | 227 | 0.350 |
Why?
| | Protein Hydrolysates | 2 | 2002 | 6 | 0.350 |
Why?
| | Insulin-Like Growth Factor I | 3 | 2021 | 319 | 0.350 |
Why?
| | Caseins | 2 | 2002 | 20 | 0.350 |
Why?
| | Maternal Age | 12 | 2020 | 126 | 0.350 |
Why?
| | Iodine | 4 | 2026 | 26 | 0.340 |
Why?
| | Social Class | 3 | 2022 | 268 | 0.340 |
Why?
| | Administration, Oral | 9 | 2026 | 847 | 0.340 |
Why?
| | Intestinal Mucosa | 7 | 2018 | 676 | 0.340 |
Why?
| | Folic Acid | 5 | 2026 | 199 | 0.330 |
Why?
| | Public Health | 4 | 2025 | 566 | 0.330 |
Why?
| | Zika Virus Infection | 2 | 2025 | 168 | 0.320 |
Why?
| | Cross-Over Studies | 7 | 2026 | 601 | 0.320 |
Why?
| | Gastrointestinal Tract | 1 | 2013 | 208 | 0.320 |
Why?
| | Failure to Thrive | 3 | 2009 | 28 | 0.320 |
Why?
| | Maternal-Child Health Services | 3 | 2019 | 12 | 0.320 |
Why?
| | Wasting Syndrome | 1 | 2010 | 12 | 0.320 |
Why?
| | Workplace | 1 | 2012 | 274 | 0.310 |
Why?
| | Plant Preparations | 1 | 2010 | 37 | 0.310 |
Why?
| | Cardiovascular Diseases | 4 | 2024 | 2168 | 0.310 |
Why?
| | Biological Transport | 3 | 2021 | 417 | 0.310 |
Why?
| | Nutritional Physiological Phenomena | 4 | 2022 | 55 | 0.300 |
Why?
| | Nutrition Surveys | 1 | 2011 | 282 | 0.300 |
Why?
| | Time Factors | 9 | 2021 | 7173 | 0.300 |
Why?
| | Absorption | 11 | 2013 | 60 | 0.290 |
Why?
| | Quality Indicators, Health Care | 1 | 2012 | 335 | 0.290 |
Why?
| | Staining and Labeling | 1 | 2009 | 151 | 0.290 |
Why?
| | Fetus | 4 | 2021 | 803 | 0.280 |
Why?
| | Neonatal Sepsis | 2 | 2026 | 8 | 0.280 |
Why?
| | Medically Underserved Area | 3 | 2018 | 101 | 0.280 |
Why?
| | Environment | 3 | 2026 | 305 | 0.280 |
Why?
| | Salmon | 2 | 2025 | 21 | 0.270 |
Why?
| | Diet Records | 5 | 2014 | 85 | 0.270 |
Why?
| | Seafood | 2 | 2025 | 26 | 0.270 |
Why?
| | Patient Safety | 1 | 2012 | 347 | 0.270 |
Why?
| | Selenium | 2 | 2025 | 49 | 0.270 |
Why?
| | Lipids | 2 | 2024 | 710 | 0.270 |
Why?
| | Practice Guidelines as Topic | 4 | 2016 | 1560 | 0.260 |
Why?
| | Logistic Models | 4 | 2021 | 2117 | 0.260 |
Why?
| | Health Knowledge, Attitudes, Practice | 6 | 2023 | 1414 | 0.260 |
Why?
| | Cytokines | 3 | 2021 | 2061 | 0.250 |
Why?
| | Folic Acid Deficiency | 2 | 2025 | 49 | 0.250 |
Why?
| | Diabetes, Gestational | 2 | 2021 | 321 | 0.250 |
Why?
| | Urinalysis | 5 | 2020 | 80 | 0.250 |
Why?
| | Pediatric Obesity | 3 | 2023 | 637 | 0.250 |
Why?
| | Adiponectin | 2 | 2018 | 244 | 0.250 |
Why?
| | Minerals | 2 | 2025 | 47 | 0.240 |
Why?
| | Communicable Diseases | 2 | 2023 | 163 | 0.240 |
Why?
| | Follow-Up Studies | 7 | 2024 | 5408 | 0.240 |
Why?
| | Referral and Consultation | 3 | 2019 | 851 | 0.230 |
Why?
| | Deoxyglucose | 1 | 2026 | 51 | 0.230 |
Why?
| | Health Personnel | 3 | 2023 | 748 | 0.230 |
Why?
| | Blueberry Plants | 1 | 2025 | 8 | 0.230 |
Why?
| | Postpartum Hemorrhage | 1 | 2026 | 28 | 0.230 |
Why?
| | Fish Products | 1 | 2025 | 7 | 0.230 |
Why?
| | Bone and Bones | 2 | 2019 | 314 | 0.230 |
Why?
| | Cause of Death | 2 | 2018 | 471 | 0.220 |
Why?
| | Colorado | 7 | 2017 | 4564 | 0.220 |
Why?
| | Risk Assessment | 7 | 2018 | 3671 | 0.220 |
Why?
| | Vitamin B 12 | 4 | 2026 | 127 | 0.220 |
Why?
| | Perinatal Care | 2 | 2018 | 62 | 0.220 |
Why?
| | Schools, Medical | 1 | 2006 | 156 | 0.220 |
Why?
| | Drug Resistance, Bacterial | 1 | 2026 | 196 | 0.210 |
Why?
| | Microcephaly | 1 | 2025 | 103 | 0.210 |
Why?
| | Internship and Residency | 2 | 2019 | 1257 | 0.210 |
Why?
| | Latin America | 6 | 2026 | 94 | 0.210 |
Why?
| | Streptococcus pneumoniae | 1 | 2026 | 177 | 0.210 |
Why?
| | Saliva | 2 | 2026 | 249 | 0.210 |
Why?
| | Parents | 1 | 2013 | 1403 | 0.210 |
Why?
| | Maternal Welfare | 2 | 2014 | 21 | 0.210 |
Why?
| | Agaricus | 1 | 2023 | 3 | 0.210 |
Why?
| | Feasibility Studies | 4 | 2023 | 1095 | 0.200 |
Why?
| | Infectious Disease Transmission, Vertical | 1 | 2026 | 193 | 0.200 |
Why?
| | Retrospective Studies | 9 | 2023 | 17066 | 0.200 |
Why?
| | Asia | 6 | 2020 | 70 | 0.200 |
Why?
| | Climate Change | 1 | 2026 | 199 | 0.200 |
Why?
| | Reference Values | 4 | 2022 | 797 | 0.200 |
Why?
| | China | 5 | 2014 | 269 | 0.200 |
Why?
| | Ferritins | 2 | 2016 | 69 | 0.200 |
Why?
| | Milk | 3 | 2018 | 119 | 0.190 |
Why?
| | Erythrocytes | 5 | 2022 | 757 | 0.190 |
Why?
| | Hot Temperature | 1 | 2026 | 407 | 0.190 |
Why?
| | Soybean Proteins | 1 | 2002 | 14 | 0.190 |
Why?
| | Vitamin A | 1 | 2023 | 59 | 0.190 |
Why?
| | Vitamin K | 1 | 2023 | 45 | 0.190 |
Why?
| | Dietary Fats, Unsaturated | 1 | 2002 | 24 | 0.190 |
Why?
| | Food Assistance | 1 | 2023 | 34 | 0.190 |
Why?
| | Plant Oils | 1 | 2002 | 31 | 0.190 |
Why?
| | Labor Presentation | 2 | 2019 | 2 | 0.190 |
Why?
| | Parenteral Nutrition | 1 | 2024 | 105 | 0.190 |
Why?
| | Infant Care | 2 | 2015 | 44 | 0.190 |
Why?
| | Pandemics | 4 | 2024 | 1694 | 0.190 |
Why?
| | Faculty, Medical | 1 | 2006 | 302 | 0.190 |
Why?
| | Respiratory Distress Syndrome, Newborn | 1 | 2023 | 106 | 0.190 |
Why?
| | Health Facilities | 2 | 2020 | 85 | 0.180 |
Why?
| | Temperature | 2 | 2023 | 679 | 0.180 |
Why?
| | Hypersensitivity | 1 | 2025 | 252 | 0.180 |
Why?
| | Dose-Response Relationship, Drug | 6 | 2019 | 2027 | 0.180 |
Why?
| | Puerperal Infection | 3 | 2024 | 5 | 0.180 |
Why?
| | Adrenal Cortex Hormones | 2 | 2016 | 478 | 0.180 |
Why?
| | Postnatal Care | 2 | 2020 | 72 | 0.180 |
Why?
| | Africa South of the Sahara | 5 | 2026 | 53 | 0.180 |
Why?
| | Prenatal Exposure Delayed Effects | 2 | 2020 | 675 | 0.180 |
Why?
| | Adolescent Health | 2 | 2019 | 37 | 0.180 |
Why?
| | Hyperglycemia | 1 | 2026 | 375 | 0.180 |
Why?
| | Fatty Acids | 3 | 2022 | 450 | 0.180 |
Why?
| | Africa | 5 | 2023 | 116 | 0.180 |
Why?
| | Midwifery | 3 | 2014 | 64 | 0.180 |
Why?
| | Intestinal Diseases | 1 | 2022 | 43 | 0.180 |
Why?
| | Zinc Oxide | 3 | 2012 | 10 | 0.180 |
Why?
| | Staphylococcus aureus | 1 | 2026 | 455 | 0.180 |
Why?
| | Tobacco, Smokeless | 1 | 2021 | 13 | 0.180 |
Why?
| | United States | 14 | 2023 | 15966 | 0.170 |
Why?
| | Biomedical Research | 3 | 2017 | 710 | 0.170 |
Why?
| | Bone Density | 3 | 2006 | 482 | 0.170 |
Why?
| | Rural Health | 5 | 2016 | 87 | 0.170 |
Why?
| | Patient Dropouts | 2 | 2012 | 65 | 0.170 |
Why?
| | Enteral Nutrition | 1 | 2024 | 216 | 0.170 |
Why?
| | Students | 1 | 2007 | 663 | 0.170 |
Why?
| | Tablets | 4 | 2022 | 41 | 0.170 |
Why?
| | Amino Acids, Essential | 1 | 2021 | 13 | 0.170 |
Why?
| | Isoleucine | 1 | 2021 | 15 | 0.170 |
Why?
| | Birth Rate | 1 | 2020 | 28 | 0.170 |
Why?
| | Selenoproteins | 1 | 2020 | 7 | 0.170 |
Why?
| | Cystic Fibrosis | 3 | 2000 | 1158 | 0.170 |
Why?
| | Animals | 17 | 2025 | 38058 | 0.160 |
Why?
| | Health Status | 1 | 2026 | 836 | 0.160 |
Why?
| | Valine | 1 | 2021 | 80 | 0.160 |
Why?
| | Phenylalanine | 1 | 2021 | 71 | 0.160 |
Why?
| | Digestive System Physiological Phenomena | 1 | 2000 | 5 | 0.160 |
Why?
| | Hyperinsulinism | 1 | 2021 | 113 | 0.160 |
Why?
| | Leucine | 1 | 2021 | 116 | 0.160 |
Why?
| | Carnitine | 1 | 2021 | 90 | 0.160 |
Why?
| | Surveys and Questionnaires | 7 | 2020 | 6048 | 0.160 |
Why?
| | Parturition | 1 | 2021 | 69 | 0.160 |
Why?
| | Treatment Outcome | 5 | 2018 | 11679 | 0.160 |
Why?
| | Oligohydramnios | 1 | 2020 | 12 | 0.160 |
Why?
| | Biotransformation | 1 | 2020 | 63 | 0.160 |
Why?
| | Cleft Lip | 1 | 2020 | 72 | 0.160 |
Why?
| | Endotoxemia | 1 | 2020 | 87 | 0.160 |
Why?
| | Linear Models | 4 | 2016 | 854 | 0.150 |
Why?
| | Pasteurization | 1 | 2019 | 2 | 0.150 |
Why?
| | Digestion | 2 | 2017 | 10 | 0.150 |
Why?
| | Quality of Health Care | 3 | 2020 | 691 | 0.150 |
Why?
| | Thinness | 2 | 2018 | 99 | 0.150 |
Why?
| | International Classification of Diseases | 1 | 2020 | 147 | 0.150 |
Why?
| | Spouses | 1 | 2021 | 108 | 0.150 |
Why?
| | Diet, Fat-Restricted | 1 | 2000 | 79 | 0.150 |
Why?
| | Lactulose | 1 | 2019 | 2 | 0.150 |
Why?
| | Cleft Palate | 1 | 2020 | 89 | 0.150 |
Why?
| | Polyhydramnios | 1 | 2019 | 17 | 0.150 |
Why?
| | Liver | 6 | 2020 | 1887 | 0.150 |
Why?
| | Calorimetry | 1 | 2019 | 72 | 0.150 |
Why?
| | Mannitol | 1 | 2019 | 40 | 0.150 |
Why?
| | Health Resources | 1 | 2020 | 129 | 0.150 |
Why?
| | Cholesterol, HDL | 2 | 2023 | 200 | 0.150 |
Why?
| | Intestines | 3 | 2019 | 358 | 0.150 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 1 | 2020 | 179 | 0.150 |
Why?
| | Hepcidins | 1 | 2019 | 22 | 0.150 |
Why?
| | Endemic Diseases | 1 | 2019 | 33 | 0.150 |
Why?
| | Anemia, Sickle Cell | 1 | 2023 | 312 | 0.150 |
Why?
| | Hypersensitivity, Immediate | 1 | 2019 | 40 | 0.140 |
Why?
| | Pilot Projects | 3 | 2023 | 1886 | 0.140 |
Why?
| | Malawi | 4 | 2015 | 57 | 0.140 |
Why?
| | Beverages | 4 | 2019 | 69 | 0.140 |
Why?
| | Species Specificity | 1 | 2020 | 574 | 0.140 |
Why?
| | Ghrelin | 1 | 2018 | 38 | 0.140 |
Why?
| | Adolescent Development | 1 | 2019 | 72 | 0.140 |
Why?
| | Middle Aged | 10 | 2025 | 35875 | 0.140 |
Why?
| | Blood Urea Nitrogen | 1 | 2018 | 53 | 0.140 |
Why?
| | Insulin-Like Growth Factor Binding Protein 3 | 1 | 2018 | 32 | 0.140 |
Why?
| | Interdisciplinary Communication | 1 | 2019 | 197 | 0.140 |
Why?
| | Glucose | 3 | 2023 | 1047 | 0.140 |
Why?
| | Oxidative Stress | 2 | 2017 | 1339 | 0.140 |
Why?
| | Meat Products | 2 | 2012 | 27 | 0.140 |
Why?
| | Erythrocyte Indices | 2 | 2021 | 33 | 0.140 |
Why?
| | Exercise | 7 | 2023 | 2201 | 0.140 |
Why?
| | Proteobacteria | 1 | 2017 | 16 | 0.130 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2020 | 594 | 0.130 |
Why?
| | Bifidobacterium | 1 | 2017 | 21 | 0.130 |
Why?
| | Clostridium | 1 | 2017 | 19 | 0.130 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2021 | 449 | 0.130 |
Why?
| | Indians, Central American | 1 | 2017 | 6 | 0.130 |
Why?
| | Food Supply | 1 | 2018 | 90 | 0.130 |
Why?
| | Cluster Analysis | 5 | 2019 | 521 | 0.130 |
Why?
| | Postoperative Complications | 2 | 2009 | 2919 | 0.130 |
Why?
| | Vaccines | 1 | 2022 | 389 | 0.130 |
Why?
| | Infusions, Intravenous | 3 | 2006 | 423 | 0.130 |
Why?
| | Isotopes | 1 | 2017 | 34 | 0.130 |
Why?
| | Guidelines as Topic | 1 | 2019 | 267 | 0.130 |
Why?
| | Appetite | 2 | 2010 | 69 | 0.130 |
Why?
| | Head | 2 | 2010 | 120 | 0.130 |
Why?
| | Copper | 3 | 2004 | 113 | 0.130 |
Why?
| | Food Analysis | 2 | 2015 | 24 | 0.120 |
Why?
| | Professional-Family Relations | 1 | 2018 | 153 | 0.120 |
Why?
| | Communication | 1 | 2023 | 965 | 0.120 |
Why?
| | Fatty Acids, Omega-6 | 1 | 2016 | 48 | 0.120 |
Why?
| | Gene Expression | 1 | 2021 | 1490 | 0.120 |
Why?
| | Social Determinants of Health | 1 | 2020 | 301 | 0.120 |
Why?
| | Dietary Sucrose | 1 | 2016 | 49 | 0.120 |
Why?
| | Interleukin-8 | 1 | 2017 | 271 | 0.120 |
Why?
| | Biomedical Technology | 1 | 2017 | 49 | 0.120 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2016 | 98 | 0.120 |
Why?
| | Intensive Care, Neonatal | 1 | 2016 | 42 | 0.120 |
Why?
| | Blood Pressure | 2 | 2020 | 1769 | 0.120 |
Why?
| | Down-Regulation | 1 | 2018 | 627 | 0.120 |
Why?
| | Population Surveillance | 4 | 2020 | 485 | 0.120 |
Why?
| | Spectrophotometry, Atomic | 8 | 2013 | 13 | 0.120 |
Why?
| | Pneumonia | 3 | 2009 | 631 | 0.120 |
Why?
| | Ethiopia | 4 | 2009 | 44 | 0.110 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2018 | 266 | 0.110 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2016 | 142 | 0.110 |
Why?
| | Reproducibility of Results | 3 | 2020 | 3409 | 0.110 |
Why?
| | Insulin Resistance | 2 | 2021 | 1241 | 0.110 |
Why?
| | Overnutrition | 1 | 2015 | 30 | 0.110 |
Why?
| | World Health Organization | 3 | 2012 | 105 | 0.110 |
Why?
| | Data Accuracy | 1 | 2015 | 65 | 0.110 |
Why?
| | Haemophilus influenzae type b | 1 | 2014 | 12 | 0.110 |
Why?
| | Bacterial Capsules | 1 | 2014 | 33 | 0.110 |
Why?
| | American Heart Association | 1 | 2016 | 350 | 0.110 |
Why?
| | Diabetes Mellitus | 4 | 2016 | 1098 | 0.110 |
Why?
| | Haemophilus Vaccines | 1 | 2014 | 29 | 0.110 |
Why?
| | Drug Utilization | 3 | 2024 | 166 | 0.110 |
Why?
| | Multivariate Analysis | 5 | 2020 | 1539 | 0.110 |
Why?
| | Antibody Affinity | 1 | 2014 | 60 | 0.110 |
Why?
| | Pregnancy in Adolescence | 1 | 2015 | 84 | 0.110 |
Why?
| | Risk Reduction Behavior | 1 | 2016 | 226 | 0.110 |
Why?
| | Chile | 2 | 2012 | 26 | 0.110 |
Why?
| | Life Style | 2 | 2015 | 479 | 0.100 |
Why?
| | Contraception Behavior | 1 | 2015 | 107 | 0.100 |
Why?
| | Placenta | 1 | 2021 | 780 | 0.100 |
Why?
| | Sequence Analysis, DNA | 1 | 2017 | 824 | 0.100 |
Why?
| | Family Planning Services | 1 | 2015 | 94 | 0.100 |
Why?
| | Stroke | 1 | 2023 | 1256 | 0.100 |
Why?
| | Cost-Benefit Analysis | 3 | 2025 | 634 | 0.100 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2017 | 338 | 0.100 |
Why?
| | Bacterial Infections | 1 | 2016 | 246 | 0.100 |
Why?
| | Up-Regulation | 1 | 2017 | 851 | 0.100 |
Why?
| | Food Preferences | 1 | 2015 | 126 | 0.100 |
Why?
| | Algorithms | 3 | 2017 | 1837 | 0.100 |
Why?
| | Antibodies, Bacterial | 1 | 2014 | 148 | 0.100 |
Why?
| | Pennisetum | 1 | 2013 | 2 | 0.100 |
Why?
| | Hair | 3 | 2011 | 88 | 0.100 |
Why?
| | Central America | 2 | 2025 | 25 | 0.100 |
Why?
| | Acrodermatitis | 1 | 2013 | 1 | 0.100 |
Why?
| | Alkaline Phosphatase | 3 | 2011 | 145 | 0.100 |
Why?
| | Population Groups | 1 | 2013 | 58 | 0.100 |
Why?
| | Pregnancy, Multiple | 1 | 2013 | 18 | 0.100 |
Why?
| | Neonatology | 1 | 2013 | 28 | 0.100 |
Why?
| | Health Services Needs and Demand | 1 | 2015 | 280 | 0.100 |
Why?
| | Qualitative Research | 1 | 2021 | 1671 | 0.100 |
Why?
| | Indicator Dilution Techniques | 4 | 2006 | 12 | 0.100 |
Why?
| | Liver Diseases | 3 | 2013 | 304 | 0.100 |
Why?
| | Puerperal Disorders | 3 | 2020 | 37 | 0.100 |
Why?
| | Health Services Accessibility | 2 | 2019 | 1098 | 0.100 |
Why?
| | Prolactin | 2 | 2007 | 89 | 0.100 |
Why?
| | Iron Radioisotopes | 1 | 2012 | 2 | 0.090 |
Why?
| | Needs Assessment | 2 | 2015 | 404 | 0.090 |
Why?
| | Puerto Rico | 2 | 2025 | 58 | 0.090 |
Why?
| | Escherichia coli | 1 | 2017 | 854 | 0.090 |
Why?
| | Endocrine System | 1 | 2012 | 22 | 0.090 |
Why?
| | Fetal Growth Retardation | 3 | 2025 | 587 | 0.090 |
Why?
| | Poverty Areas | 1 | 2012 | 42 | 0.090 |
Why?
| | Leukocyte L1 Antigen Complex | 1 | 2012 | 40 | 0.090 |
Why?
| | Urban Health | 1 | 2012 | 96 | 0.090 |
Why?
| | Child Development Disorders, Pervasive | 1 | 2012 | 62 | 0.090 |
Why?
| | Hospitals, University | 1 | 2012 | 176 | 0.090 |
Why?
| | Triglycerides | 1 | 2014 | 520 | 0.090 |
Why?
| | Mammary Glands, Human | 1 | 2012 | 67 | 0.090 |
Why?
| | Intestine, Small | 2 | 2011 | 166 | 0.090 |
Why?
| | Analysis of Variance | 3 | 2002 | 1306 | 0.090 |
Why?
| | Ferrous Compounds | 3 | 2026 | 25 | 0.090 |
Why?
| | Obstetrics | 1 | 2013 | 175 | 0.090 |
Why?
| | Erythrocyte Membrane | 1 | 2011 | 54 | 0.090 |
Why?
| | Zika Virus | 2 | 2025 | 132 | 0.090 |
Why?
| | Cerebrovascular Disorders | 1 | 2012 | 103 | 0.090 |
Why?
| | Morphogenesis | 1 | 2012 | 173 | 0.090 |
Why?
| | Clinical Competence | 1 | 2019 | 1244 | 0.080 |
Why?
| | Chickens | 1 | 2011 | 191 | 0.080 |
Why?
| | International Agencies | 1 | 2011 | 30 | 0.080 |
Why?
| | Spectrometry, Mass, Fast Atom Bombardment | 4 | 1998 | 7 | 0.080 |
Why?
| | Incidence | 4 | 2019 | 2879 | 0.080 |
Why?
| | Digestive System | 2 | 2001 | 28 | 0.080 |
Why?
| | Curriculum | 3 | 2019 | 1059 | 0.080 |
Why?
| | Single-Blind Method | 1 | 2011 | 312 | 0.080 |
Why?
| | Growth Charts | 1 | 2010 | 20 | 0.080 |
Why?
| | Inositol Phosphates | 1 | 2010 | 21 | 0.080 |
Why?
| | Dexamethasone | 1 | 2012 | 372 | 0.080 |
Why?
| | Interleukin-6 | 1 | 2014 | 780 | 0.080 |
Why?
| | Food, Formulated | 1 | 1989 | 15 | 0.080 |
Why?
| | Language | 1 | 2013 | 321 | 0.080 |
Why?
| | Argentina | 3 | 2014 | 30 | 0.080 |
Why?
| | Interviews as Topic | 1 | 2014 | 901 | 0.080 |
Why?
| | Physicians | 2 | 2019 | 939 | 0.080 |
Why?
| | Family Nursing | 1 | 2009 | 12 | 0.080 |
Why?
| | Manganese | 1 | 1989 | 55 | 0.080 |
Why?
| | Public Assistance | 1 | 2009 | 19 | 0.080 |
Why?
| | Child Welfare | 1 | 2012 | 231 | 0.080 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2014 | 1217 | 0.070 |
Why?
| | Program Evaluation | 1 | 2014 | 948 | 0.070 |
Why?
| | Blood Glucose | 2 | 2021 | 2327 | 0.070 |
Why?
| | Respiratory Hypersensitivity | 1 | 2009 | 65 | 0.070 |
Why?
| | Mexico | 1 | 2009 | 233 | 0.070 |
Why?
| | Cattle | 2 | 2024 | 1000 | 0.070 |
Why?
| | Patient Acceptance of Health Care | 1 | 2015 | 885 | 0.070 |
Why?
| | Patient Compliance | 1 | 2012 | 588 | 0.070 |
Why?
| | Congo | 2 | 2020 | 4 | 0.070 |
Why?
| | Hospitals, Pediatric | 1 | 2012 | 556 | 0.070 |
Why?
| | Celiac Disease | 1 | 2011 | 308 | 0.070 |
Why?
| | Health Planning Guidelines | 1 | 2007 | 24 | 0.070 |
Why?
| | Ascorbic Acid | 1 | 2009 | 180 | 0.070 |
Why?
| | Safety | 1 | 2010 | 356 | 0.070 |
Why?
| | Urban Population | 3 | 2018 | 491 | 0.070 |
Why?
| | Food Handling | 2 | 2025 | 63 | 0.070 |
Why?
| | Nutrition Disorders | 1 | 2007 | 20 | 0.070 |
Why?
| | Disease Management | 1 | 2012 | 645 | 0.070 |
Why?
| | Fatty Acids, Volatile | 2 | 2018 | 60 | 0.060 |
Why?
| | Child Behavior | 1 | 2009 | 236 | 0.060 |
Why?
| | Combined Modality Therapy | 1 | 2010 | 1266 | 0.060 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2021 | 2583 | 0.060 |
Why?
| | Cognition | 2 | 2009 | 1266 | 0.060 |
Why?
| | Injections, Intravenous | 3 | 2004 | 200 | 0.060 |
Why?
| | Mutation | 2 | 2013 | 4089 | 0.060 |
Why?
| | Sensitivity and Specificity | 2 | 2009 | 1985 | 0.060 |
Why?
| | Diphosphates | 1 | 2026 | 20 | 0.060 |
Why?
| | Carrier Proteins | 2 | 2002 | 737 | 0.060 |
Why?
| | Edetic Acid | 1 | 2026 | 47 | 0.060 |
Why?
| | Sex Factors | 2 | 2010 | 2112 | 0.060 |
Why?
| | Research Design | 2 | 2019 | 1135 | 0.060 |
Why?
| | Blood Transfusion | 2 | 2026 | 405 | 0.060 |
Why?
| | Proteins | 1 | 2012 | 1021 | 0.060 |
Why?
| | Stress, Physiological | 1 | 2009 | 453 | 0.060 |
Why?
| | Aged | 3 | 2023 | 25913 | 0.060 |
Why?
| | South America | 1 | 2025 | 57 | 0.060 |
Why?
| | Postprandial Period | 2 | 1997 | 118 | 0.060 |
Why?
| | Xanthophylls | 1 | 2025 | 19 | 0.060 |
Why?
| | Isomerism | 1 | 2025 | 57 | 0.060 |
Why?
| | Sex Characteristics | 1 | 2011 | 790 | 0.060 |
Why?
| | Problem-Based Learning | 1 | 2006 | 98 | 0.060 |
Why?
| | Malaria, Falciparum | 1 | 2005 | 33 | 0.050 |
Why?
| | Vitamin B 12 Deficiency | 1 | 2025 | 77 | 0.050 |
Why?
| | Education, Medical, Continuing | 1 | 2006 | 132 | 0.050 |
Why?
| | Energy Metabolism | 2 | 2015 | 935 | 0.050 |
Why?
| | Caregivers | 1 | 2014 | 1049 | 0.050 |
Why?
| | Fruit | 1 | 2025 | 152 | 0.050 |
Why?
| | Obstetric Labor, Premature | 2 | 2016 | 39 | 0.050 |
Why?
| | Gastroplasty | 1 | 2004 | 32 | 0.050 |
Why?
| | Schools | 1 | 2007 | 453 | 0.050 |
Why?
| | Spleen | 2 | 2020 | 508 | 0.050 |
Why?
| | Health Behavior | 2 | 2023 | 785 | 0.050 |
Why?
| | Drug Administration Schedule | 1 | 2026 | 779 | 0.050 |
Why?
| | Delivery of Health Care | 2 | 2022 | 947 | 0.050 |
Why?
| | Zinc Radioisotopes | 1 | 2003 | 1 | 0.050 |
Why?
| | Hydroxyurea | 1 | 2023 | 34 | 0.050 |
Why?
| | Home Childbirth | 2 | 2013 | 5 | 0.050 |
Why?
| | Palm Oil | 1 | 2002 | 3 | 0.050 |
Why?
| | Calcium Compounds | 1 | 2022 | 6 | 0.050 |
Why?
| | Ethers | 1 | 2022 | 19 | 0.050 |
Why?
| | Mice, Inbred C57BL | 3 | 2020 | 5992 | 0.050 |
Why?
| | Sodium Chloride | 1 | 2023 | 141 | 0.050 |
Why?
| | Oxides | 1 | 2022 | 51 | 0.050 |
Why?
| | Phosphatidylethanolamines | 1 | 2022 | 76 | 0.050 |
Why?
| | Docosahexaenoic Acids | 1 | 2022 | 83 | 0.040 |
Why?
| | Genetic Engineering | 1 | 2002 | 93 | 0.040 |
Why?
| | Reference Standards | 1 | 2002 | 177 | 0.040 |
Why?
| | Multicenter Studies as Topic | 1 | 2023 | 405 | 0.040 |
Why?
| | Cholesterol | 1 | 2023 | 406 | 0.040 |
Why?
| | Community Health Services | 1 | 2023 | 233 | 0.040 |
Why?
| | Evidence-Based Medicine | 1 | 2005 | 732 | 0.040 |
Why?
| | Phospholipids | 1 | 2022 | 213 | 0.040 |
Why?
| | Magnesium | 2 | 2001 | 155 | 0.040 |
Why?
| | Glutathione Peroxidase | 1 | 2020 | 39 | 0.040 |
Why?
| | Stress, Psychological | 1 | 2009 | 1152 | 0.040 |
Why?
| | Animals, Newborn | 2 | 2014 | 902 | 0.040 |
Why?
| | Pregnancy Trimester, Second | 2 | 2019 | 82 | 0.040 |
Why?
| | Metallothionein | 1 | 2000 | 25 | 0.040 |
Why?
| | Orosomucoid | 1 | 2020 | 9 | 0.040 |
Why?
| | Circadian Rhythm | 1 | 1985 | 514 | 0.040 |
Why?
| | Glucose Tolerance Test | 1 | 2021 | 361 | 0.040 |
Why?
| | Vaccination | 2 | 2022 | 1423 | 0.040 |
Why?
| | Licensure | 1 | 2019 | 16 | 0.040 |
Why?
| | Nicaragua | 1 | 2019 | 7 | 0.040 |
Why?
| | Zinc Sulfate | 2 | 2012 | 8 | 0.040 |
Why?
| | Child Abuse | 1 | 2005 | 551 | 0.040 |
Why?
| | Severity of Illness Index | 2 | 2011 | 2925 | 0.040 |
Why?
| | Colombia | 1 | 2019 | 42 | 0.040 |
Why?
| | Peru | 1 | 2019 | 62 | 0.040 |
Why?
| | Hepatocytes | 1 | 2020 | 223 | 0.040 |
Why?
| | National Heart, Lung, and Blood Institute (U.S.) | 1 | 2019 | 103 | 0.040 |
Why?
| | Sequence Analysis, RNA | 1 | 2022 | 442 | 0.040 |
Why?
| | Accreditation | 1 | 2019 | 101 | 0.040 |
Why?
| | Family Relations | 1 | 2000 | 88 | 0.040 |
Why?
| | Brazil | 1 | 2019 | 180 | 0.040 |
Why?
| | Term Birth | 1 | 2018 | 25 | 0.040 |
Why?
| | HIV Infections | 1 | 2014 | 3154 | 0.040 |
Why?
| | Asia, Southeastern | 1 | 2018 | 13 | 0.040 |
Why?
| | Amniotic Fluid | 1 | 2019 | 79 | 0.040 |
Why?
| | Germ-Free Life | 1 | 2018 | 33 | 0.040 |
Why?
| | Least-Squares Analysis | 1 | 1998 | 76 | 0.040 |
Why?
| | Rhinitis, Allergic | 1 | 2019 | 42 | 0.040 |
Why?
| | Gene Expression Regulation | 2 | 2021 | 2608 | 0.040 |
Why?
| | Eczema | 1 | 2019 | 66 | 0.030 |
Why?
| | Organ Specificity | 2 | 2014 | 312 | 0.030 |
Why?
| | Microwaves | 1 | 1998 | 31 | 0.030 |
Why?
| | Focus Groups | 1 | 2021 | 573 | 0.030 |
Why?
| | Immunoglobulin M | 1 | 2019 | 284 | 0.030 |
Why?
| | Diet, Western | 1 | 2018 | 86 | 0.030 |
Why?
| | Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2001 | 293 | 0.030 |
Why?
| | Odds Ratio | 1 | 2020 | 1075 | 0.030 |
Why?
| | C-Reactive Protein | 1 | 2020 | 416 | 0.030 |
Why?
| | Hospitals, Maternity | 1 | 2017 | 4 | 0.030 |
Why?
| | Pressure | 1 | 1998 | 225 | 0.030 |
Why?
| | Bile Acids and Salts | 1 | 2018 | 164 | 0.030 |
Why?
| | Food-Drug Interactions | 1 | 2017 | 11 | 0.030 |
Why?
| | Tuberculosis | 1 | 2000 | 291 | 0.030 |
Why?
| | Health Care Surveys | 1 | 2019 | 539 | 0.030 |
Why?
| | Fermentation | 1 | 2017 | 32 | 0.030 |
Why?
| | Dysbiosis | 1 | 2018 | 187 | 0.030 |
Why?
| | Liquid-Liquid Extraction | 1 | 2016 | 14 | 0.030 |
Why?
| | Chromatography, Gas | 1 | 2016 | 32 | 0.030 |
Why?
| | Food Hypersensitivity | 1 | 2019 | 164 | 0.030 |
Why?
| | Lactobacillales | 1 | 2016 | 5 | 0.030 |
Why?
| | Gammaproteobacteria | 1 | 2016 | 13 | 0.030 |
Why?
| | Continuity of Patient Care | 1 | 2019 | 291 | 0.030 |
Why?
| | Phosphates | 1 | 1997 | 180 | 0.030 |
Why?
| | Ambulatory Care Facilities | 1 | 2018 | 265 | 0.030 |
Why?
| | Pyruvate Kinase | 1 | 2016 | 28 | 0.030 |
Why?
| | Absorptiometry, Photon | 1 | 1997 | 276 | 0.030 |
Why?
| | Community Health Centers | 1 | 2016 | 59 | 0.030 |
Why?
| | Plethysmography | 1 | 2016 | 108 | 0.030 |
Why?
| | Computer Simulation | 1 | 2000 | 1025 | 0.030 |
Why?
| | Kidney | 2 | 2020 | 1495 | 0.030 |
Why?
| | Drug Interactions | 1 | 2017 | 398 | 0.030 |
Why?
| | Dermatitis, Atopic | 1 | 2019 | 321 | 0.030 |
Why?
| | Reproductive Behavior | 1 | 2015 | 11 | 0.030 |
Why?
| | RNA, Viral | 1 | 2019 | 688 | 0.030 |
Why?
| | Pancreas | 1 | 1998 | 341 | 0.030 |
Why?
| | Antibodies, Viral | 1 | 2019 | 672 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2020 | 2115 | 0.030 |
Why?
| | Dental Caries | 1 | 2016 | 173 | 0.030 |
Why?
| | Gene Expression Profiling | 1 | 2022 | 1782 | 0.030 |
Why?
| | Medical History Taking | 1 | 1995 | 117 | 0.030 |
Why?
| | Absorption, Physiological | 1 | 2014 | 4 | 0.030 |
Why?
| | Students, Medical | 1 | 2019 | 375 | 0.030 |
Why?
| | Vaccines, Conjugate | 1 | 2014 | 60 | 0.030 |
Why?
| | Fetal Proteins | 1 | 1994 | 15 | 0.030 |
Why?
| | Insulin-Like Growth Factor II | 1 | 1994 | 24 | 0.030 |
Why?
| | Kinetics | 3 | 2007 | 1627 | 0.030 |
Why?
| | Serum Albumin | 3 | 1999 | 147 | 0.030 |
Why?
| | Health | 1 | 2014 | 81 | 0.030 |
Why?
| | Bacteria | 1 | 2020 | 889 | 0.030 |
Why?
| | Patient Care Planning | 1 | 2015 | 169 | 0.030 |
Why?
| | Healthcare Disparities | 1 | 2020 | 727 | 0.030 |
Why?
| | Tissue Distribution | 1 | 2014 | 327 | 0.030 |
Why?
| | Physical Examination | 1 | 1995 | 239 | 0.020 |
Why?
| | Estradiol | 1 | 1997 | 533 | 0.020 |
Why?
| | Maternal-Fetal Exchange | 1 | 2014 | 169 | 0.020 |
Why?
| | Uruguay | 1 | 2013 | 2 | 0.020 |
Why?
| | Amino Acids | 1 | 1997 | 521 | 0.020 |
Why?
| | Pregnancy, Twin | 1 | 2013 | 19 | 0.020 |
Why?
| | Contraception | 1 | 2015 | 169 | 0.020 |
Why?
| | Hypertension | 2 | 2016 | 1263 | 0.020 |
Why?
| | Morbidity | 1 | 2014 | 323 | 0.020 |
Why?
| | Lung | 2 | 2020 | 4109 | 0.020 |
Why?
| | Fetal Mortality | 1 | 2012 | 4 | 0.020 |
Why?
| | DNA Replication | 1 | 1994 | 251 | 0.020 |
Why?
| | South Australia | 1 | 2011 | 4 | 0.020 |
Why?
| | Clinical Trials as Topic | 1 | 2017 | 1053 | 0.020 |
Why?
| | Liver Transplantation | 1 | 1999 | 823 | 0.020 |
Why?
| | Mammary Glands, Animal | 1 | 2012 | 128 | 0.020 |
Why?
| | Healthy Volunteers | 1 | 2012 | 215 | 0.020 |
Why?
| | Breath Tests | 1 | 2011 | 79 | 0.020 |
Why?
| | Metabolic Diseases | 1 | 2012 | 114 | 0.020 |
Why?
| | Sucrose | 1 | 2011 | 112 | 0.020 |
Why?
| | Carbon Isotopes | 1 | 2011 | 144 | 0.020 |
Why?
| | Clinical Protocols | 1 | 2012 | 282 | 0.020 |
Why?
| | Disease Susceptibility | 1 | 2012 | 348 | 0.020 |
Why?
| | Risk | 1 | 2013 | 911 | 0.020 |
Why?
| | Health Surveys | 1 | 2012 | 518 | 0.020 |
Why?
| | Swimming | 1 | 2009 | 50 | 0.020 |
Why?
| | Ovalbumin | 1 | 2009 | 190 | 0.020 |
Why?
| | Cytotoxicity, Immunologic | 1 | 2009 | 223 | 0.020 |
Why?
| | Leukocyte Count | 1 | 2009 | 316 | 0.020 |
Why?
| | Models, Theoretical | 1 | 2012 | 582 | 0.020 |
Why?
| | Corticosterone | 1 | 2009 | 244 | 0.020 |
Why?
| | Biopsy | 1 | 2011 | 1075 | 0.020 |
Why?
| | Protein Deficiency | 1 | 2007 | 4 | 0.020 |
Why?
| | Interleukins | 1 | 2009 | 248 | 0.020 |
Why?
| | Immunoglobulin E | 1 | 2009 | 315 | 0.020 |
Why?
| | Asthma | 1 | 2019 | 1767 | 0.020 |
Why?
| | Mice | 2 | 2018 | 18339 | 0.020 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2009 | 636 | 0.020 |
Why?
| | Counseling | 1 | 2010 | 408 | 0.020 |
Why?
| | Mice, Inbred BALB C | 1 | 2009 | 1253 | 0.020 |
Why?
| | Self Efficacy | 1 | 2010 | 414 | 0.010 |
Why?
| | Food, Genetically Modified | 1 | 2006 | 2 | 0.010 |
Why?
| | Adolescent Nutritional Physiological Phenomena | 1 | 2006 | 29 | 0.010 |
Why?
| | Plants, Genetically Modified | 1 | 2006 | 15 | 0.010 |
Why?
| | Biliary Atresia | 1 | 1987 | 158 | 0.010 |
Why?
| | Killer Cells, Natural | 1 | 2009 | 467 | 0.010 |
Why?
| | Sweat | 1 | 1986 | 51 | 0.010 |
Why?
| | Gallstones | 1 | 2005 | 35 | 0.010 |
Why?
| | Antimalarials | 1 | 2005 | 35 | 0.010 |
Why?
| | Chloroquine | 1 | 2005 | 53 | 0.010 |
Why?
| | Placebos | 1 | 2005 | 192 | 0.010 |
Why?
| | Isotope Labeling | 1 | 2005 | 82 | 0.010 |
Why?
| | Mental Competency | 1 | 2004 | 26 | 0.010 |
Why?
| | Parental Consent | 1 | 2004 | 25 | 0.010 |
Why?
| | Anorexia | 1 | 1984 | 17 | 0.010 |
Why?
| | Family Characteristics | 1 | 2005 | 197 | 0.010 |
Why?
| | Primary Prevention | 1 | 2005 | 220 | 0.010 |
Why?
| | Parent-Child Relations | 1 | 2005 | 270 | 0.010 |
Why?
| | Informed Consent | 1 | 2004 | 198 | 0.010 |
Why?
| | Models, Statistical | 1 | 2007 | 681 | 0.010 |
Why?
| | Gastrointestinal Transit | 1 | 2002 | 6 | 0.010 |
Why?
| | Body Fluid Compartments | 1 | 2002 | 7 | 0.010 |
Why?
| | Free Radicals | 1 | 2001 | 110 | 0.010 |
Why?
| | Radioactive Tracers | 1 | 2000 | 4 | 0.010 |
Why?
| | Mass Screening | 1 | 2010 | 1347 | 0.010 |
Why?
| | Mental Recall | 1 | 2003 | 222 | 0.010 |
Why?
| | Phosphorus | 1 | 2001 | 99 | 0.010 |
Why?
| | Gastric Mucosa | 1 | 2000 | 52 | 0.010 |
Why?
| | Urine | 1 | 2000 | 62 | 0.010 |
Why?
| | Blood | 1 | 2000 | 109 | 0.010 |
Why?
| | Patient Selection | 1 | 2004 | 719 | 0.010 |
Why?
| | Diabetes Complications | 1 | 2001 | 222 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2012 | 8265 | 0.010 |
Why?
| | Patient Education as Topic | 1 | 2004 | 780 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2009 | 4557 | 0.010 |
Why?
| | Eating | 1 | 2000 | 389 | 0.010 |
Why?
| | Postoperative Period | 1 | 1999 | 354 | 0.010 |
Why?
| | Creatinine | 1 | 1999 | 506 | 0.010 |
Why?
| | Acute Disease | 1 | 1999 | 1030 | 0.010 |
Why?
| | Software | 1 | 2000 | 690 | 0.010 |
Why?
| | North America | 1 | 1995 | 310 | 0.010 |
Why?
| | Europe | 1 | 1995 | 412 | 0.010 |
Why?
| | Chronic Disease | 1 | 1999 | 1813 | 0.010 |
Why?
| | Sheep | 1 | 1994 | 880 | 0.010 |
Why?
| | Erythrocyte Transfusion | 1 | 1989 | 231 | 0.000 |
Why?
| | Urinary Tract Infections | 1 | 1989 | 202 | 0.000 |
Why?
| | Cells, Cultured | 1 | 1994 | 4154 | 0.000 |
Why?
| | RNA, Messenger | 1 | 1994 | 2832 | 0.000 |
Why?
| | Surgical Wound Infection | 1 | 1989 | 316 | 0.000 |
Why?
| | Blood Proteins | 1 | 1983 | 249 | 0.000 |
Why?
|
|
Krebs's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|